Clinical Trials Logo

Primary Raynaud Disease clinical trials

View clinical trials related to Primary Raynaud Disease.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02212249 Completed - Systemic Sclerosis Clinical Trials

Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis

Sclerocadh1
Start date: May 2014
Phase: N/A
Study type: Interventional

Ve-cadherin is expressed in endothelial cells. Systemic slerosis is a rare auto-immune disease with a endothelial dysfunction. This study is to evaluated the level of soluble VE-cadherin and VE-cadherin antibody in patients with systemic slerosis.